Affordable Access

Publisher Website

Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

Authors
Type
Published Article
Journal
American Journal of Respiratory and Critical Care Medicine
1535-4970
Publisher
American Thoracic Society
Publication Date
Volume
184
Issue
5
Pages
561–568
Identifiers
DOI: 10.1164/rccm.201012-2090OC
PMID: 21562125
Source
Medline

Abstract

These results suggest that aerosolized albuterol does not improve clinical outcomes in patients with ALI. Routine use of β₂-agonist therapy in mechanically ventilated patients with ALI cannot be recommended. Clinical trial registered with www.clinicaltrials.gov (NCT 00434993).

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments